Acorda Therapeutics, Inc. (ACOR) PT Raised to 'Street High' $35 at Cowen
Tweet Send to a Friend
Cowen analyst Phil Nadeau raised the price target on Acorda Therapeutics, Inc. (NASDAQ: ACOR) to $35.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
